Wenxia Du
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Si-Si-Gu-Ben granules alleviate diarrhea-predominant irritable bowel syndrome by modulating gut microbiota and suppressing the TLR4/NF-κB pathway: A combined clinical and animal study.
Journal: Journal of ethnopharmacology
Published: May 12, 2026
Vasicine Attenuates Allergic Asthma by Suppressing Mast Cell Degranulation and Th2 Inflammation via Modulation of the FcεRI/Lyn + Syk/MAPK Pathway.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 02, 2025
Piperlonguminine attenuates atherosclerosis in mice via phenotype switching inhibition of vascular smooth muscle cells.
Journal: European journal of pharmacology
Published: October 20, 2025
Development of new dehydrocostuslactone derivatives for treatment of atopic dermatitis via inhibition of the NF-κB signaling pathway.
Journal: RSC medicinal chemistry
Published: April 27, 2024
Vasicine attenuates atherosclerosis via lipid regulation, inflammation inhibition, and autophagy activation in ApoE-/- mice.
Journal: International immunopharmacology
Published: February 26, 2024
Exploration of costunolide derivatives as potential anti-inflammatory agents for topical treatment of atopic dermatitis by inhibiting MAPK/NF-κB pathways.
Journal: Bioorganic chemistry
Published: October 18, 2023
Inhibitory effects of catalpol on DNCB-induced atopic dermatitis and IgE-mediated mast cells reaction.
Journal: International immunopharmacology
Published: September 16, 2023
Vasicine alleviates 2,4-dinitrochlorobenzene-induced atopic dermatitis and passive cutaneous anaphylaxis in BALB/c mice.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 09, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026